SBFM
Sunshine BiopharmaCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
Current thesis
Composite grade C from latest DB weights. Momentum 41.5 / Value 57.6
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.4.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
42
Value
58
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $56.00
Why
Momentum42 · Δ7d -
Value58 · Δ7d -0.4
SentimentN/A · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
42
40% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
58
60% active weight
Current posture
7d trendFlat
Δ7d
-0.4
Δ21d
-0.4
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 41.5 / Value 57.6
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$3.67M
Beta
1.71
Shares Out
2.12M
P/E (TTM) · Derived
-0.1
P/S (TTM)
0.17
P/FCF (TTM) · Derived
-0.14
Rev YoY
-9.1%
EPS YoY
-41.9%
Gross Margin
+32.0%
Op Margin
-17.3%
Net Debt
-$8.31M
Current Ratio
4.22
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology